TELA Bio (TELA) Payables (2018 - 2026)

TELA Bio has reported Payables for 9 years, with the latest figure at $2.9 million in Q2 2026.

• On a quarterly basis, Payables rose 65.59% year-over-year to $2.9 million in Q2 2026; TTM through Jun 2026 was $2.9 million, a 65.59% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 7.55% from the prior year.
• Payables was $2.9 million for Q2 2026 at TELA Bio, down from $3.9 million in the prior quarter.
• The five-year high for Payables was $5.7 million in Q1 2022, with the low at $1.5 million in Q4 2022.
• Average Payables over 5 years is $3.0 million, with a median of $2.4 million recorded in 2024.
• The largest YoY upside for Payables was 490.98% in 2022 against a maximum downside of 36.45% in 2022.
• Over 5 years, Payables stood at $1.5 million in 2022, then climbed by 8.67% to $1.7 million in 2023, then gained by 28.79% to $2.1 million in 2024, then rose by 7.55% to $2.3 million in 2025, then grew by 24.86% to $2.9 million in 2026.
• The last three Payables figures came in at $2.9 million (Q2 2026), $3.9 million (Q1 2026), and $2.3 million (Q4 2025), per Business Quant data.